Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 2 X users

patent: 4 patents

Citations

dimensions_citation: 98 Dimensions

Readers on

mendeley: 108 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Methods of treating severe inflammation

Grant US-11931418-B2

United States of America

DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY

Application WO-2021113651-A3

World Intellectual Property Organisation (WIPO)

Arginase inhibitors and their therapeutic applications

Grant US-10912755-B2

United States of America

Dipeptide piperidine derivatives

Grant US-10851099-B2

United States of America